While initial estimates placed the interferon beta drugs market value at USD 4.5 billion in 2023, more recent research suggests a valuation of USD 4.6 billion for that year. Looking ahead, the market is projected to exhibit a CAGR of 4.30% between 2024 and 2032, reaching a value of USD 6.2 billion by 2032.
Immunomodulatory drugs, also known as immune system modulators, are a diverse...
English
Arabic
Français
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian